TILT HoldingsTLLTF Net Margin % is -115.03% as of Jun. 2025. The stock has 4 warning signs investors should review. Among 956 Drug Manufacturers companies, TILT Holdings ranks worse than 91.11% on this metric.
Net margin is calculated as Net Income divided by its Revenue. TILT Holdings's Net Income for the
three
months ended in Jun. 2025 was $-12.06 Mil. TILT Holdings's Revenue for the
three
months ended in Jun. 2025 was $10.49 Mil. Therefore, TILT Holdings's net margin for the quarter that ended in Jun. 2025 was -115.03%.
The historical rank and industry rank for TILT Holdings's Net Margin % or its related term are showing as below:
TLLTF'
s Net Margin % Range Over the Past 10 Years
Min: -15708.71 Med: -66.76 Max: -17.33
Current: -93.67
TLLTF's Net Margin % is ranked worse than 91.11% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs TLLTF: -93.67
TILT Holdings (OTCPK:TLLTF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
TILT Holdings Net Margin % Related Terms
TILT Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for TILT Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TLLTF vs FLHLF, STEK, NXEN: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, TILT Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TILT Holdings Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TILT Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where TILT Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TILT Holdings (TLLTF) has a Net Margin % of -115.03% as of Jun. 2025. Net margin is the ratio of total net income to net sales. View historical data on TILT Holdings and its competitors. According to the industry distribution chart, TILT Holdings ranks #871 out of 956 companies in the Drug Manufacturers industry, placing it in the top 91.1%.
Is TILT Holdings' Net Margin % too high?
TILT Holdings' current Net Margin % is -115.03%. Based on the distribution chart, TILT Holdings ranks #871 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does TILT Holdings' Net Margin % compare to FLHLF and STEK?
According to the Drug Manufacturers industry distribution chart, TILT Holdings ranks #871 out of 956 companies for Net Margin %. This places TILT Holdings in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on TILT Holdings and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TILT Holdings's current Net Margin % is -115.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TILT Holdings stock overvalued right now?
TILT Holdings (TLLTF) has a current Net Margin % of -115.03%. The stock's GF Value™ is $0.02, compared to a current price of $0.00 — trading 99.5% below its estimated fair value. The current Net Margin % is -115.03%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For TILT Holdings (TLLTF), the current Net Margin % is -115.03% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TILT Holdings Inc is a business solutions provider to the cannabis industry. The company helps cannabis businesses build brands through a portfolio of companies providing technology, hardware, cultivation, and production. The operating segments of the company are Cannabis and Accessories. The majority of the revenue is generated from the Accessories segment which is engaged in the manufacturing and distribution of electronic, non-nicotine (i.e., cannabis) devices and systems. The company's geographical segments include the United States, Canada, and others, of which the majority of the revenue is generated from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TLLTF has been successfully added to your 